Диссертация (1097235), страница 68
Текст из файла (страница 68)
Impactof addiction severity and psychiatric comorbidity on the quality of life of alcohol–, drug– and dual–dependent persons in residential treatment // Eur. Addict. Res. –2013. – Vol.19 (4). – P.173-183.551. Copeland J. A randomized controlled trial of brief cognitive–behavioral intervention for cannabis use disorder // Journal of Substance AbuseTreatment. – 2001. – Vol.21. – P.55-64.552. Corbin J., Strauss A. Basics of qualitative research: Techniques andprocedures for developing grounded theory (3rd ed.).
– Thousand Oaks, CA: Sage,2007. – 379 р.553. Cottler L.B., Compton WM., Веn-Аbdаllah А. et al. Achieving а 96.6percent follow–up in а longitudinal study of drug abusers // Drug A1cohol.Depend. – 1996. – Vol. 41. – Р. 209-217.554. Cousijn J., Goudriaan A.E., Ridderinkhof K.R.
et al. Approach–biaspredicts development of cannabis problem severity in heavy cannabis users: resultsfrom a prospective FMRI study // PLoS One. – 2012. – Vol.7 (9). – P. 42394.555. Cunningham J.A. Remissions from drug dependence: is treatment аprerequisite? // Drugю Alcohol Depend.
– 2000. – Vol. 59, № 3. – Р. 211-213.556. Danovitch I., Gorelick D.A. State of the art treatments for cannabisdependence // Psychiatr. Clin. North Am. – 2012. – Vol.35 (2). – P. 309-326.557. Darke S., Ross J., Teesson М. et al. Factors associated with 12 monthcontinuous heroin abstinence: findings from the Australian Treatment Outcome453Study (ATOS) // J. Subst. Abuse Nreat. – 2005. – Vol. 28, № 3.
– Р. 255-263.558. Darke S., McDonald S., Kaye S., Torok M. Comparative patterns ofcognitiveperformanceamongstopioidmaintenancepatients,abstinentopioid users and non-opioid users // Drug Alcohol Depend. – 2012. – Vol.126 (3).– P. 309-315.559. Day E., Copello A., Seddon J. et al. Pilot study of a social networkintervention for heroin users in opiate substitution treatment: study protocol for arandomized controlled trial // Trials. – 2013. – Vol.14 (1). – P. 264.560. Deacon B.J. The biomedical model of mental disorder: A criticalanalysis of its validity, utility, and effects on psychotherapy research // Clin.Psychol. Rev.
– 2013. – Vol.33 (7). – P. 846-861.561. Defulio A., Stitzer M., Roll J. et al. Criminal justice referral andincentives in outpatient substance abuse treatment // J. Subst. Abuse Treat. – 2013.– Vol.45 (1). – P. 70-75.562. De Leon G. Therapeutic Communities // Textbook of SubstanceAbuse Treatment / Ed by Marc Galanter, M.D., Herbert D., Kleber, M.D.– TheAmerican Psychiatric Press, 2nd Edition. – Washington, 1999.
– Р. 459-477.563. De Leon G. Community as а method: Therapeutic Communities forspecial population and special settings. – Westport, Connecticut: PraegerPublishiers, 1997. – 140 р.564. Deyell R.J., Lorenzi M., Ma S. et al. Antidepressant use amongsurvivors of childhood, adolescent and young adult cancer: a report of theChildhood, Adolescent and Young Adult Cancer Survivor (CAYACS) ResearchProgram // Pediatr.
Blood Cancer. – 2013. – Vol.60 (5). – P.816-822.565. Dhawan A., Chopra A. Does buprenorphine maintenance improve thequality of life of opioid users? // Indian J. Med. Res. – 2013. – Vol.137 (1). – P.130-135.566. Diaz S., Secades-Villa R., Errasti Perez J. et al. Family predictors ofparent participation in an adolescent drug abuse prevention program // Drug and454Alcohol Review. – 2006. – Vol. 25, № 4. – P.327331.567.
Dickerson D., Robichaud F., Teruya C. et al. Utilizing drumming forAmerican Indians/Alaska Natives with substance use disorders: a focus groupstudy // Am. J. Drug Alcohol Abuse. – 2012. – Vol.38 (5). – P.505-510.568. Downey L., Rosengren D.B., Donovan D.M. Gender, waitlists, andoutcomes for public-sector drug treatment // Journal of Substance AbuseTreatment. – 2003. – Vol.25, № l. – P.19-28.569.
Eack Sh.M., Hogarty S.S., Greenwald D.P., Bahorik A.L., LitschgeM.Y., Bangalore S.S., Pogue-Geile M.F., Cornelius J.R. Integrated cognitiveenhancement therapy and personal therapy for substance misusing schizophreniapatients: Interim results on the first 6 months of treatment // Drug and AlcoholDependence. – 2014. – Volume 140. P. e53.570.
Effectiveness and costs of inpatient versus day hospital cocainerehabilitation // J. Nervous and Mental Disease. – 1994. – Vol. 182. – P.157-163.571. Epstein D.H., Preston K.L. Daily life hour by hour, with and withoutcocaine: an ecological momentary assessment study // Psychopharmacology (Berl).– 2010. – Vol.211 (2).
– P.223-232.572. Farquharson G. Adolescents, Тherapeutic Communities and MaxwellJones // Int. J. Тher. Communities. – 1991. – Vol. 12. – Р. 2-3.573. Fassino S., Abbate Daga G., Delsedime N. et al. Quality of life andpersonality disorders in heroin abusers // Drug and Alcohol Dependence. – 2004. –Vol.76, № 1. – P.73-80.574. Fattore L. Considering gender in cannabinoid research: a step towardspersonalized treatment of marijuana addicts // Drug Test Anal. – 2013.
– Vol.5 (1).– P. 57-61.575. Fernandez-Artamendi S., Fernandez-Hermida J.R., Garia-FernandezG. et al. Motivation for change and barriers to treatment among youngcannabis users // Eur. Addict. Res. – 2013. – Vol.19 (1). – P. 29-41.576. Fiorentine R., Anglin D. More is better: counselling participation and455the effectiveness of outpatient drug treatment // J. Substance Abuse Treatment. –1996. – Vol. 13. – P. 241-248.577. Fiorentine R., Anglin M.D.
Does increasing the opportunity forcounseling increase the effectiveness of outpatient drug treatment? // American J.of Drug and Alcohol Abuse. – 1997. – Vol. 23, № 3. – P.369-382.578. Fishbein М., Middlestadt S.E., Hitchcock P.J. Using information tochange sexually transmitted disease-related behaviors: ап analysis based оп thetheory of reasoned action // In R.J. Diclimente & J.L. Peterson, AIDS: theories andmethods of behaviour interventions. New York: Plenum Press, 1994. – P. 231-298.579. Fisher C.B. Addiction research ethics and the Belmont principles:do drug users have a different moral voice? // Subst Use Misuse. – 2011. – Vol.46(6).
– P. 728-741.580. Franken I.H., Hendriks V.M., Haffmans P.M., Van-der-Meer C.W.Coping style of substance-abuse patients: effects of anxiety and mood disorders oncoping change // J. Clin. Psychol. – 2001. – Vol.57(3). – P. 299-306.581. Franken I.H., Hendriks V. M., Van–den– Brink W. Initial validationof two opiate craving questionnaires: The Obsessive Compulsive Drug Scale andthe Desires for Drug Questionnaire // Addictive–Behaviors. – 2002. – Vol. 27(5). –P. 675-685.582. Frei M.
Opioid dependence – management in general practice // Aust.Fam. Physician. – 2010. – Vol.39 (8). – P.548-552.583. Frick U., Wiedermann W., Schaub M. et al. Prognostic factors from along-term follow-up of heroin-assisted treatment in Switzerland 1994–2007 //Psychiatr. Prax. – 2010. – Vol.37 (4). – P.175-182.584. Frontera Walter R. Research priorities in rehabilitation medicine // In.Journal of Rehabilitation Research. - 2009 - Volume 32 - Issue 4 –P. 279.585. Gabatz R.I., Schmidt A.L., Terra M.G. et al. Perception ofcrack users in relation to use and treatment // Rev. Gaucha Enferm. – 2013. –Vol.34 (1). – P.140-146.456586.
Galanter M., Dermatis H., Post S., Sampson C. Spirituality-basedrecovery from drug addiction in the twelve-step fellowship of narcotics anonymous// J. Addict. Med. – 2013. – Vol.7 (3). – P.189-195.587. Galanter M., Dermatis H., Bunt G., et al Assessment of spiritualityand its relevance to addiction treatment // Journal of Substance Abuse Treatment. –2007. – Vol. 33, № 3.
– P. 257-264.588. Garscia-Rodriguez O., Secades-Villa R., Alvarez O. et al. Efecto delos incentivos sobre la retencion en un tratamiento ambulatorio para adictos a lacocaina // Psicthema. – 2007. – Vol.19. – P. 134-139.589. Gastfriend D.R. Intramuscular extended-release naltrexone: currentevidence // Ann. N Y Acad Sci. – 2011.
– Vol. 1216. – Р. 144-166.590. Geisler B.P., Ghosh A. Gabapentin treatment for alcohol dependence// JAMA Intern. Med. – 2014. – Vol. 174 (7). – P. 1201.591. German Ch.L., Fleckenstein A.E., Hanson G.R. Bath salts andsynthetic cathinones: An emerging designer drug phenomenon // Life Sciences. –2014. – Vol. 97, Issue 1. – Pages 2-8.592. Gervasoni J.P., Balthasar H., Huissoud T.
et al. A high proportion ofusers of low-threshold facilities with needle exchange programs in Switzerland arecurrently on methadone treatment: implications for new approaches in harmreduction and care // Int. J. Drug. Policy. – 2012. – Vol. 23 (1). – P.33-36.593. Giancola P.R., Parker A.M.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
